China slams US bill targeting biotech firms as 'discriminatory'
Tweet
Share
E-mail
FILE PHOTO: The logo of Chinese drug research and development group WuXi AppTec is displayed alongside its company website, in this illustration picture taken February 5, 2024. REUTERS/Florence Lo/Illustration/File Photo
BEIJING (Reuters) - The United State's passage of a bill that aims to restrict business with Wuxi AppTec, BGI and other biotech firms was a "discriminatory" measure against Chinese companies, China's foreign ministry said on Tuesday.
China urges the U.S. to respect market principles and trade rules, stop pushing forward the bill and misusing all kinds of excuses to suppress Chinese companies, ministry spokesperson Mao Ning said at a press briefing.
(Reporting by Colleen Howe and Beijing Newsroom; Editing by Christian Schmollinger)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta settlement falls short on teen mental health protections, whistleblower says
- Fed's Collins says latest US inflation readings are 'mixed'
- Eswatini receives two more third-country deportees from US, government says
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
